SCHEMBL8309705

SCHEMBL8309705

COCCNCCC[NH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10938938 0.90 MAPK1 (0.42)
SCHEMBL8310482 0.84
SCHEMBL8327575 0.84 KDM4E (0.46)
SCHEMBL6223853 0.81 ALDH1A1 (0.46)
SCHEMBL11119 0.81
SCHEMBL8310094 0.80
Fluoride SCHEMBL25246136 0.78 KDM4E (0.42)
SCHEMBL3631301 0.78 KDM4E (0.42)
Hydrochloric Acid SCHEMBL2532416 0.78 L3MBTL1 (0.43)
Iodide SCHEMBL1835511 0.78 KDM4E (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed